10/20/2026
UT MD Anderson experts are advancing cancer research at the 2026 ESMO - European Society for Medical Oncology this week.
Dr. Jennifer Litton highlights five studies exploring ways to increase genetic testing among at-risk families, monitor circulating tumor DNA in early-stage triple-negative breast cancer and evaluate new treatment approaches for advanced cancers.
Read Dr. Litton’s overview of the research: http://spr.ly/6187BHpEcR
UT MD Anderson experts are presenting new research at the 2026 ESMO Congress, exploring advances in genetic testing, cancer monitoring and treatment. Dr. Jennifer Litton highlights five studies with the potential to improve care for people with cancer.